Pharma hailed as major contributor to Spanish R&D

Spanish industry body Farmaindustria reports that 19% of R&D spend in Spain is from pharmaceutical companies.

Almost one in every five Euros spent on research and development (R&D) in Spain comes from pharma, and Farmaindustria points out these companies are responsible for only 2.7% of industrial turnover in the country. The report also says:

“Likewise, the sector is a leader in R&D employment, with more than 5,800 people employed, and two thirds of them, women, which means that one in three researchers employed in the Spanish industrial sector works in the pharmaceutical industry. Furthermore, as the Report reflects, it is the industrial sector with the most patent applications in Spain in 2019.

The President of the Association, Martín Sellés, said:

“We are demonstrating that our sector is strategic for the country from the triple health, economic and social perspective. Spain must find solid sectors, based on innovation and knowledge, on which to support the obligatory reactivation…

“This is the line of work we are in, reinforced with our data and our facts. We are part of the solution that Spain needs for its future, and we will work with the Administration and with the whole of society for the health, economic and social boost that we want for our country.”

Read the full report through Farmaindustria.

Tagged with

Published on 15. July 2020 in News, News Spain, Press Release